Author | Erin Kayata

Articles

FDA Approves Apalutamide for Prostate Cancer

September 18, 2019

Apalutamide was initially approved in 2018 for patients with non-metastatic castration-resistant prostate cancer; the recent approval is for patients with metastatic castration-sensitive prostate cancer.